1
Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid
Condition(s):Idiopathic Inflammatory Myopathies; Osteoporosis, OsteopeniaLast Updated:July 26, 2019Unknown status
Zoledronic Acid: 391 Clinical Trials, Page 1 of 40
Hide Studies Not Open or Pending
2
Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma
Condition(s):LeiomyosarcomaLast Updated:June 3, 2022Recruiting
3
Efficacy of Zoledronic Acid in Osteoporosis of Children With Multiple Disabilities
Condition(s):Multiple Disability; OsteoporosisLast Updated:October 4, 2017Completed
4
Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole
Condition(s):Use of Zoledronic Acid in Breast CancerLast Updated:December 21, 2021Recruiting
5
Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis
Condition(s):OsteoporosisLast Updated:February 21, 2021Completed
6
A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)
Condition(s):OsteoporosisLast Updated:May 4, 2022Recruiting
7
Zoledronic Acid in Rheumatoid Arthritis
Condition(s):Arthritis, RheumatoidLast Updated:February 22, 2019Terminated
8
Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Condition(s):Osteoporosis; Osteoporosis, Postmenopausal; Osteopenia; Bone LossLast Updated:November 4, 2022Recruiting
9
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
Condition(s):Osteoporosis; Osteonecrosis; Acute Lymphoblastic LeukemiaLast Updated:August 22, 2018Withdrawn
10
The Effect of Zoledronate on the Prevention of Pneumonia in Hip Fracture Patients
Condition(s):Hip Fractures; PneumoniaLast Updated:February 24, 2023Recruiting